Astrazeneca (AZN) EBIT Margin (QoQ) (2009 - 2026)
Astrazeneca (AZN) EBIT Margin (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.81 Bn | 633.06 Bn | 17.26 Bn |
| 2 | AbbVie | 469.85 Bn | 463.28 Bn | 12.70 Bn |
| 3 | Merck | 375.13 Bn | 367.99 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.67 Bn | 294.98 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.60 Bn | 252.70 Bn | 12.86 Bn |
| 6 | Amgen | 237.08 Bn | 223.09 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.35 Bn | 180.18 Bn | 6.22 Bn |
| 8 | Pfizer | 160.17 Bn | 148.47 Bn | 10.94 Bn |
| 9 | Gsk | 105.99 Bn | 101.83 Bn | 8.24 Bn |
| 10 | Sanofi | 55.21 Bn | 47.83 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -549,372.00 |
| Mar 31, 2026 | -4.41 Mn |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 3.25 Mn |
| Jun 30, 2025 | -494,060.00 |
| Mar 31, 2025 | 471,505.00 |
| Dec 31, 2024 | -331,968.00 |
| Sep 30, 2024 | -6.51 Mn |
| Jun 30, 2024 | 6.17 Mn |
| Mar 31, 2024 | 472,695.00 |
| Dec 31, 2023 | 18,084.00 |
| Sep 30, 2023 | 74,189.00 |
| Jun 30, 2023 | -816,820.00 |
| Mar 31, 2023 | 775,530.00 |
| Dec 31, 2022 | 98,600.00 |
| Sep 30, 2022 | -1.73 Mn |
| Jun 30, 2022 | 1.76 Mn |
| Mar 31, 2022 | 39,723.00 |
| Dec 31, 2021 | 128,228.00 |
| Sep 30, 2021 | -198,320.00 |